Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPICURE: EPO + Iron for Anemic TAVR Patients
NCT02390102Phase 3Completed
- Start
- Jun 2012
- Primary completion
- Jun 2015
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia. Started Jun 2012; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02390102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390102.